Investor Insight: Oncolytics Biotech Inc. (ONCY) Goes Ballistic – Investor Confidence on the Rise
Oncolytics Biotech Inc. (NASDAQ:ONCY) shares traded -10.32% lower at $2.52 on Wall Street last session. In accordance with the data, 7 analysts cover Oncolytics Biotech Inc. (NASDAQ:ONCY). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $15.00 and a low of $4.46, […]